Type 2 diabetes presenting with DKA and severe hypertriglyceridaemia


  • Sing Yee Sim University Hospitals of Leicester NHS Trust
  • Marie-France Kong University Hospitals of Leicester NHS Trust
  • Faizanur Rahman University Hospitals of Leicester NHS Trust




diabetic ketoacidosis, hypertriglyceridaemia, ApoE2, lipoprotein lipase, pancreatitis


GAD antibodies. Diapedia. https://www.diapedia.org/type-1-diabetes-mellitus/21042821246/gad-antibodies (accessed 15 Aug 2018).

Umpierrez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS, Phillips LS. Diabetic ketoacidosis in obese African-Americans. Diabetes 1995; 44:790–5.

Gotoda T, Shirai K, Ohta T, et al. Diagnosis and management of type I and type V hyperlipoproteinemia. J Atheroscler Thromb 2012;19:1–12.

Stroes E, Moulin P, Parhofer KG, Rebours V, Löhr JM, Averna M. Diagnostic algorithm for familial chylomicronemia syndrome. Atheroscler Suppl 2017;23:1–7. https://doi.org/10.1016/j.atherosclerosissup.2016.10.002

de Beer F, Stalenhoef AF, Hoogerbrugge N, et al. Expression of type III hyperlipoproteinemia in apolipoprotein E2 (Arg158 --> Cys) homozygotes is associated with hyperinsulinemia. Arterioscler Thromb Vasc Biol 2002;22:294–9.

Melnick S, Nazir S, Gish D, Raj Aryal M. Hypertriglyceridemic pancreatitis associated with confounding laboratory abnormalities. J Community Hosp Intern Med Perspect 2016;6(3):31808. https://doi.org/10.3402/jchimp.v6.31808.

Anderson F, Thomson SR, Clarke DL, Buccimazza I. Dyslipidaemic pancreatitis clinical assessment and analysis of disease severity and outcomes. Pancreatology 2009;9:252–257. https://doi.org/10.1159/000212091

Jabbar MA, Zuhri-Yafi MI, Larrea J. Insulin therapy for a non-diabetic patient with severe hypertriglyceridemia. J Am Coll Nutr 1998;17:458–61.

Rosenson RS. Fenofibrate: treatment of hyperlipidemia and beyond. Expert Rev Cardiovasc Ther 2008;6:1319–30. https://doi.org/10.1586/14779072.6.10.1319

Jones PH, Davidson MH, Stein EA, et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial). Am J Cardiol 2003;92:152–60.

Harris WS, Ginsberg HN, Arunakul N, et al. Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk 1997;4:385–91.

Chaudhary A, Umair Iqbal, Anwar H, Siddiqui HU, Alvi M. Acute pancreatitis secondary to severe hypertriglyceridemia: management of severe hypertriglyceridemia in emergency setting. Gastroenterol Res 2017; 10:190–2. https://doi.org/10.14740/gr762e

Preiss D, McMurray JJ, Sattar N. Treatment of severe hypertriglyceridaemia. Lancet Diabetes Endocrinol 2014:2:860. https://doi.org/10.1016/S2213-8587(14)70052-X

Nasstrom B, Stegmayr BG, Olivecrona G, Olivecrona T. Lower plasma levels of lipoprotein lipase after infusion of low molecular weight heparin than after administration of conventional heparin indicate more rapid catabolism of the enzyme. J Lab Clin Med 2003;142:90–9. https://doi.org/10.1016/S0022-2143(03)00059-3

Betteridge DJ, Bakowski M, Taylor KG, et al. Treatment of severe diabetic hypertriglyceridemia by plasma exchange. Lancet 1978;1(8078):1368. https://doi.org/10.1016/S0140-6736(78)92450-9

Yeh JH, Chen JH, Chiu HC. Plasmapheresis for hyperlipidemic pancreatitis. J Clin Apher 2003;18:181–5. https://doi.org/10.1002/jca.10063




Most read articles by the same author(s)

1 2 > >>